158 related articles for article (PubMed ID: 19656347)
1. Leprosy in a renal transplant recipient: review of the literature.
Guditi S; Ram R; Ismal KM; Sahay M; Dakshinamurthy KV; Girish N; Prasad N
Transpl Infect Dis; 2009 Dec; 11(6):557-62. PubMed ID: 19656347
[TBL] [Abstract][Full Text] [Related]
2. Lepromatous leprosy in a kidney transplant recipient: a case report.
Ardalan M; Ghaffari A; Ghabili K; Shoja MM
Exp Clin Transplant; 2011 Jun; 9(3):203-6. PubMed ID: 21649570
[TBL] [Abstract][Full Text] [Related]
3. Two microbiological relapses in a patient with lepromatous leprosy.
Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
[TBL] [Abstract][Full Text] [Related]
4. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
[TBL] [Abstract][Full Text] [Related]
5. [Histoid leprosy with erythema nodosum leprosum].
Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
[TBL] [Abstract][Full Text] [Related]
6. Leprosy in transplant recipients: report of a case after liver transplantation and review of the literature.
Trindade MA; Palermo ML; Pagliari C; Valente N; Naafs B; Massarollo PC; D'Albuquerque LA; Benard G
Transpl Infect Dis; 2011 Feb; 13(1):63-9. PubMed ID: 20678090
[TBL] [Abstract][Full Text] [Related]
7. Bullous erythema nodosum leprosum: a case report from Nepal.
Rijal A; Agrawal S; Agarwalla A; Lakhey M
Lepr Rev; 2004 Jun; 75(2):177-80. PubMed ID: 15282970
[TBL] [Abstract][Full Text] [Related]
8. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
Vijayakumaran P; Manimozhi N; Jesudasan K
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
[TBL] [Abstract][Full Text] [Related]
9. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
10. Lepromatous iridocyclitis.
Citirik M; Batman C; Aslan O; Adabag A; Ozalp S; Zilelioglu O
Ocul Immunol Inflamm; 2005 Feb; 13(1):95-9. PubMed ID: 15804778
[TBL] [Abstract][Full Text] [Related]
11. A case of relapse with drug-susceptible M. leprae after multidrug therapy.
Constant-Desportes M; Guelpa-Lauras CC; Carolina JC; Léoture A; Grosset JH; Sansarricq H
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):242-7. PubMed ID: 2071981
[TBL] [Abstract][Full Text] [Related]
12. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
[TBL] [Abstract][Full Text] [Related]
13. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
Kar HK; Sharma P
Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
[TBL] [Abstract][Full Text] [Related]
14. Does clofazimine (B663) reach Mycobacterium leprae persisting in Schwann cells and endothelial cells of endoneurial blood vessels in peripheral nerves?
Kumar V
Microsc Res Tech; 2008 Aug; 71(8):614-8. PubMed ID: 18567015
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Becx-Bleumink M; Berhe D
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
[TBL] [Abstract][Full Text] [Related]
16. Resolution of lepromatous leprosy after a short course of amoxicillin/clavulanic acid, followed by ofloxacin and clofazimine.
Villahermosa LG; Walsh DS; Fajardo TT; Abalos RM; dela Cruz EC; Veerasubramanian P; Walsh GP
Int J Dermatol; 1999 Jul; 38(7):558-60. PubMed ID: 10440294
[No Abstract] [Full Text] [Related]
17. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
[TBL] [Abstract][Full Text] [Related]
18. Concomitant lucio phenomenon and erythema nodosum in a leprosy patient: clues for their distinct pathogeneses.
Benard G; Sakai-Valente NY; Bianconcini Trindade MA
Am J Dermatopathol; 2009 May; 31(3):288-92. PubMed ID: 19384072
[TBL] [Abstract][Full Text] [Related]
19. Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study.
Ebenezer GJ; Job A; Abraham S; Arunthathi S; Rao PS; Job CK
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):292-7. PubMed ID: 10575409
[TBL] [Abstract][Full Text] [Related]
20. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
Armour KS; Scolyer RA; Barnetson RS
Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
